Entrada Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | 11/14/2024 | 4.87 M | $77.76 M | 0.00% | 11.98% |
MPM ASSET MANAGEMENT LLC | 11/13/2024 | 4.43 M | $70.72 M | 0.00% | 10.89% |
5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 4.41 M | $70.45 M | 0.00% | 10.85% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.05 M | $48.73 M | -2.71% | 7.51% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.82 M | $29.13 M | 100.00% | 4.49% |
FMR LLC | 11/13/2024 | 1.74 M | $27.86 M | -4.68% | 4.29% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.71 M | $27.36 M | 10.45% | 4.21% |
VANGUARD GROUP INC | 11/13/2024 | 1.22 M | $19.55 M | 8.28% | 3.01% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 1.03 M | $16.45 M | -0.44% | 2.53% |
STEPSTONE GROUP LP | 11/12/2024 | 761,277 | $12.17 B | 0.00% | 1.87% |
TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 584,955 | $9.35 M | 0.00% | 1.44% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 576,451 | $9.21 M | 8.78% | 1.42% |
STATE STREET CORP | 11/14/2024 | 469,601 | $7.50 M | 5.48% | 1.16% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 201,803 | $3.22 M | 50.33% | 0.50% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 185,984 | $2.97 M | 14.56% | 0.46% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 138,605 | $2.21 M | 132.36% | 0.34% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 129,866 | $2.08 M | 5.70% | 0.32% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 110,943 | $1.77 M | -24.69% | 0.27% |
MOORE CAPITAL MANAGEMENT, LP | 11/14/2024 | 105,000 | $1.68 M | 0.00% | 0.26% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 104,967 | $1.68 M | -16.32% | 0.26% |
MARSHALL WACE, LLP | 11/14/2024 | 100,106 | $1.60 M | 51.81% | 0.25% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/14/2024 | 99,697 | $1.59 M | 596.84% | 0.25% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 95,408 | $1.53 M | 100.00% | 0.23% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 93,800 | $1.50 M | 110.31% | 0.23% |
MORGAN STANLEY | 11/14/2024 | 93,266 | $1.49 M | 90.14% | 0.23% |
CITADEL ADVISORS LLC | 11/14/2024 | 88,224 | $1.41 M | -32.37% | 0.22% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 84,466 | $1.35 M | 153.64% | 0.21% |
FIRST TRUST ADVISORS LP | 11/13/2024 | 81,549 | $1.30 M | 100.00% | 0.20% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 69,394 | $1.11 M | 100.00% | 0.17% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 65,523 | $1.04 M | 390.18% | 0.16% |
CORTON CAPITAL INC. | 11/14/2024 | 57,849 | $924,427 | 5.23% | 0.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 57,331 | $916,149 | 100.00% | 0.14% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 56,855 | $908,543 | -0.43% | 0.14% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 50,725 | $810,586 | -86.82% | 0.12% |
NAN FUNG GROUP HOLDINGS LTD | 11/13/2024 | 49,082 | $784,330 | 0.00% | 0.12% |
LPL FINANCIAL LLC | 11/08/2024 | 48,844 | $780,527 | 100.00% | 0.12% |
TD ASSET MANAGEMENT INC | 11/01/2024 | 47,788 | $786,113 | -32.98% | 0.12% |
BARCLAYS PLC | 11/19/2024 | 45,110 | $720,000 | 210.57% | 0.11% |
SQUAREPOINT OPS LLC | 11/14/2024 | 41,568 | $664,257 | 60.19% | 0.10% |
XTX TOPCO LTD | 11/14/2024 | 39,670 | $633,927 | 100.00% | 0.10% |
AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 39,468 | $630,699 | 100.00% | 0.10% |
LAZARD ASSET MANAGEMENT LLC | 11/14/2024 | 39,441 | $630,000 | 1,179.72% | 0.10% |
STRS OHIO | 11/01/2024 | 38,500 | $615,230 | 34.62% | 0.09% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 38,107 | $608,950 | 181.29% | 0.09% |
MARTINGALE ASSET MANAGEMENT L P | 11/14/2024 | 37,923 | $606,010 | 36.92% | 0.09% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 36,577 | $585,000 | 71.78% | 0.09% |
RHUMBLINE ADVISERS | 11/12/2024 | 36,298 | $580,033 | -1.74% | 0.09% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 34,061 | $544,294 | 17.74% | 0.08% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 33,932 | $542,233 | 100.00% | 0.08% |
SWISS NATIONAL BANK | 11/07/2024 | 32,800 | $524,144 | 0.00% | 0.08% |
Entrada Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 102 institutional investors and hedge funds held shares of Entrada Therapeutics, Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 4.87 M
MPM ASSET MANAGEMENT LLC: 4.43 M
5AM Venture Management, LLC: 4.41 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.05 M
BlackRock Funding, Inc. /DE: 1.82 M
FMR LLC: 1.74 M
74.09% of Entrada Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 31.51 M shares in the last 24 months. This purchase volume represents approximately $393.55 M in transactions.